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Abstract
Over 383,900 individuals in the U.S. undergo maintenance hemodialysis that exposes them to 
water, primarily in the form of dialysate. The quality of water and associated dialysis solutions 
have been implicated in adverse patient outcomes and is therefore critical. The Association for the 
Advancement of Medical Instrumentation has published both standards and recommended 
practices that address both water and the dialyzing solutions. Some of these recommendations 
have been adopted into Federal Regulations by the Centers for Medicare and Medicaid Services as 
part of the Conditions for Coverage, which includes limits on specific contaminants within water 
used for dialysis, dialysate, and substitution fluids. Chemical, bacterial, and endotoxin 
contaminants are health threats to dialysis patients, as shown by the continued episodic nature of 
outbreaks since the 1960s causing at least 592 cases and 16 deaths in the U.S. The importance of 
the dialysis water distribution system, current standards and recommendations, acceptable 
monitoring methods, a review of chemical, bacterial, and endotoxin outbreaks, and infection 
control programs are discussed.
By the end of 2010, a total of 594,374 people had end-stage renal disease (ESRD) in the 
United States (1). Of the total number of people with ESRD, the prevalent dialysis 
(hemodialysis and peritoneal dialysis) and transplant population was 415,013 and 179,361, 
respectively (1). Of the patients treated by dialysis, over 383,900 receive maintenance 
hemodialysis. Patients undergoing hemodialysis ‘three times per week’ can be exposed to 
300–600 l of water depending on their prescription (2,3). The volume of dialysis fluid 
increases for those on nocturnal treatments to 580–860 l per week (3). Ensuring the 
necessary quality of dialysate is a vital aspect of this type of treatment considering the 
repeated, large volumes each patient is subjected to. Specifically, chemical, bacterial, and 
associated endotoxin contamination can threaten a dialysis patient’s health. Dialysis patients 
often have additional comorbidities (e.g., diabetes, hypertension, cardiovascular disease, 
etc.) that can make them more vulnerable to adverse outcomes. Aging, obesity, and 
hypertension rates are also increasing in the U.S. population, which are associated with 
ESRD and chronic kidney disease (4). Thus, more individuals will probably need renal 
replacement therapy (maintenance hemodialysis, peritoneal dialysis, or transplantation). 
Asserting that water and dialysate quality is an important factor in protecting the health of 
hemodialysis patients is an understatement.
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Drinking water is treated, purified, and transported through a distribution system within a 
dialysis center where it is used in the preparation of dialysate concentrates, as well as for 
proportioning concentrates at the dialysis machine to produce the final dialysate bath. All of 
these steps provide an opportunity for microbial growth or chemical exposure if the water is 
contaminated and not properly maintained. The main water sources for hemodialysis 
facilities, as well as for home dialysis treatments, are local drinking water suppliers. 
Municipalities and other drinking water suppliers are required to adhere to the U.S. 
Environmental Protection Agency (EPA) drinking water standards under the Safe Drinking 
Water Act (SDWA), which specifies chemical and microbiological contaminant levels. The 
dialysis staff must be cognizant of their incoming water quality and the provider’s treatment 
practices prior to beginning dialysis prep and dialysis treatment. Dialysis centers and their 
employees are also required to meet the Centers for Medicare and Medicaid Services (CMS) 
Conditions for Coverage, which includes various requirements intended to ensure the safe 
treatment of dialysis patients (5).
The current CMS rules were published in 2008 (5) and are based upon recommendations 
made in 2004 by the Association for the Advancement of Medical Instrumentation (AAMI) 
(6). While the 2008 CMS regulations are directed at maintenance of hemodialysis facilities 
and are the minimum standards for water for dialysis and dialysate quality, the 2009 and 
2011 updated recommendations by AAMI are more stringent and are voluntary (7,8). All of 
these guidelines and recommendations focus on the quality management of dialysis 
treatment, of which water or dialysate are the main topic.
Guidelines and recommendations are necessary due to the potential health outcomes for 
dialysis patients if exposed to chemical or microbiological contaminants. Chemical 
contaminants can cause chemical toxicity and adverse effects if present at high enough 
concentrations. Chemical toxicity leads to a range of clinical outcomes, including but not 
limited to, speech and motor difficulties, seizures, nausea, hypotension, and diarrhea. Each 
chemical produces a specific reaction; for example, sulfate (>200 mg/l) is associated with 
nausea, vomiting, and metabolic acidosis (9), while lead (52–65 μg/l) has caused abdominal 
pain and muscle weakness (10). While there are defined ranges where toxicity is likely to 
occur, each person has a specific threshold before clinical symptoms will appear due to 
various physiological reasons and the individuals’ health status.
Some chemicals are not inherently toxic in nature, but, if present in high enough 
concentrations, they can cause adverse health effects. Calcium is one such example, where 
excessive amounts have been associated with renal disease (11). Meanwhile, microbial 
contaminated dialysis water and/or dialysate may produce bacteremia and chronic 
inflammation, which contributes to or complicates the leading cause of death for dialysis 
patients, cardiovascular disease (CVD). Endotoxin fragments or endotoxin in the dialysate 
bath may pass through the dialyzer membranes or cause transmembrane stimulation of 
circulating immune cells to produce symptoms of septicemia or a pyrogenic reaction. The 
presence of dialysate contaminants also triggers inflammatory markers, such as high-
sensitivity C-reactive protein, interleukin (IL)-6, fibrinogen, and intercellular adhesion 
molecule (sICAM-1) (12). Chronic inflammation, in addition to contributing to CVD, has 
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been linked to the following clinical outcomes: poor nutritional status, reduced response to 
erythropoietin therapy, decline in residual renal function, and carpal tunnel syndrome (13).
With two available guidance documents and continuing sporadic outbreaks, as well as a 
multitude of contaminants, hemodialysis options, and monitoring approaches, an updated 
review was necessary to consolidate the current information. This review describes the 
dialysis water distribution system and appropriate materials; dialysis quality with regard to 
current standards; methods for identifying chemical, bacterial, and endotoxin contaminants; 
outbreaks that were caused by chemical and microbiological agents; and the importance of 
infection control.
Dialysis Water Distribution System and Materials
Once water enters a hemodialysis center, the goal is to achieve high quality and safe 
hemodialysis water and dialysate. Water treatment, system design, and distribution material 
choices are contributing factors. Dialysis water treatment should remove chemical and 
microbial contaminants to below established allowable limits and is characterized by two 
phases: (i) pretreatment, where constituents are removed from the feed water to protect the 
downstream treatment components and (ii) water treatment, which is the process of 
physically removing and/or chemically inactivating remaining chemical and/or microbial 
contaminants. Details regarding water treatment options and typical designs have already 
been given (8,14,15), but are briefly described here. Pretreatment includes the following: a 
blend valve – i.e., temperature controller to aid in efficient treatment downstream; 
multimedia depth filtration – composed of sand and/or coal, where the goal is to remove 
solids; granular activated carbon (GAC) filter(s) – absorb(s) organic matter that influences 
taste, odor, color, toxicity, and mutagenicity; softener – reduces the presence of cations 
(Ca2+, Mg2+, Sr2+, Fe2+, and Mn2+), which is measured as the ‘hardness of water’ and is 
commonly expressed as the concentration (mg/l) of CaCO3 (16); and a prefilter – removes 
remaining particles (e.g., particulates and fine particles released from the GAC filters) prior 
to treatment. Water treatment includes reverse osmosis (RO) with/without deionization (DI) 
tanks, followed by these optional components: storage tank, ultraviolet (UV) irradiator, and 
ultrafilter/endotoxin-retentive filter (always used after storage tank, UV irradiator, or DI 
tank). RO is capable of excluding metal ions, aqueous salts, and molecules from the treated 
water. Ultrafiltration and endotoxin-retentive filters can be included after the deionizer, 
immediately after the storage tank, and/or before delivery to the dialyzer (depending on the 
design of the system) (13) to remove bacteria and endotoxin by using a positively charged 
filter surface and size exclusion.
There are two types of system designs, indirect and direct, for distribution of the treated 
water before the water is combined with the concentrates to make dialysate. Indirect systems 
constantly circulate water through the previously described pretreatment/treatment, even 
when the machines are not in use, and route the unused treated water back to the point 
before RO treatment or to a storage tank after the RO. Direct systems are one-way and when 
the machines are off, the water is stagnant. The direct system design is not recommended 
due to the opportunity for microbial growth and biofilm formation that can occur during 
periods of low or no flow. If a storage tank is incorporated into the loop, the tanks should 
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have a conical/bowl shape base and tight lid with hydrophobic air filter (0.22–0.45 μm), and 
should be cleaned and disinfected regularly (e.g., weekly, bi-weekly, monthly, etc.) as 
determined by monthly (or established monitoring schedule) bacteriological results and 
visual assessment (8).
Although the exact role that biofilms in the water distribution system play is not defined for 
hemodialysis patients (17), outbreak data demonstrate that it is in the patients’ interest to 
have water and dialysis solutions that are as “microbiologically clean” as possible. 
Unfortunately, biofilms are highly resistant to disinfectants due to the mixed bacterial 
community’s structure and the formation of exopolysaccharides (EPS). Preventing the initial 
growth of a biofilm is recommended, and part of this tactic includes choosing appropriate 
materials for the dialysis water distribution system, in combination with compatible 
disinfection.
The AAMI 2011 recommendations include a material compatibility list in Table B.1 for 
commonly used materials in the distribution system and available disinfectants (8). The 
materials listed were polyvinylchloride (PVC), chlorinated polyvinylchloride (CPVC), 
polyvinylidene fluoride (PVDF), cross-linked polyethylene (PEX), stainless steel (SS), 
polypropylene (PP), polyethylene (PE), acrylonitrile butadiene styrene (ABS), and 
polytetrafluorethylene (PTFE). The disinfectants included were sodium hypochlorite 
(chlorine bleach), peracetic acid, formaldehyde, hot water, and ozone (dissolved in water). 
Peracetic acid was listed as compatible with all distribution materials. Incompatibilities 
between distribution materials and disinfectants were sodium hypochlorite with SS and 
ABS; formaldehyde with ABS; hot water with PVC, CPVC, PE, and ABS; and ozone with 
PP and ABS. The incompatibilities could cause leaching or corrosion of the materials, which 
may pose a risk to the patients or integrity of the system.
While the AAMI table offers a general list of materials, PVC (Type 1, Schedule 40 or 80) 
and SS (316L) are the two most used in hemodialysis systems. PVC is the more common 
substratum used due to availability and cost; however, an evaluation showed that purified 
water, chemical disinfection, and water flow ‘wore’ the material down over time (14 years) 
to create a surface that supported bacterial growth (18). In addition, the connections within a 
system must be welded or joined properly, so as to not create any rough edges where 
bacteria can proliferate; and proper angles are recommended to allow for an even flow (19).
Standards and Methods
When hemodialysis was introduced as a treatment for acute renal failure patients around 
1945 (20), the importance of water and dialysate quality with regard to chemicals and 
microorganisms was not well recognized (21). This was in part because, until the 1960s, the 
procedure itself was not widespread and patients received a limited number of treatments. 
Even after hemodialysis became a mainstream therapy following the development of the 
Scribner shunt permanent vascular access in 1960, water quality was only factored in by 
controlling temperature and conductivity on the untreated source waters used for dialysis 
(21). This may have been a reflection of geography, as Ward pointed out, because in the 
beginning, the epicenter for hemodialysis was in the northwestern U.S. at the University of 
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Washington in Seattle where the water quality is comparatively better than in other regions 
(21). Additionally, drinking water quality was not standardized until 1974 when the Safe 
Drinking Water Act (SDWA) was enacted.
The first chemicals of concern for dialysis water were those with a natural presence in the 
source waters or as drinking water additives for public health reasons (e.g., disinfection, 
preventing dental caries) (21). Thus, water treatment as part of hemodialysis became normal 
protocol and the first standards were published in 1981 by AAMI. While water treatment 
technology has advanced, assuring adequate quality of dialysate will continue to be 
complex. The continuous changes in municipal water treatment due to new EPA regulations 
or seasonal fluctuations, the use of new dialyzer designs (i.e., high-flux), and expansion of 
dialyzer reuse (21) are a few examples creating this complexity. As previously mentioned, 
the current Conditions for Coverage (42 CFR Parts 405, 410, 413, 414, 488, 494) published 
by CMS for water and dialysate quality became a Final Rule in 2008 (5) and were based in 
part upon the 2004 AAMI document, “Dialysate for Hemodialysis” (6).
AAMI has since updated the recommendations (8), specifically for the microbiological 
methods and standards for hemodialysis concentrates (11), water for hemodialysis (11), 
water treatment and related therapies (22), and dialysis fluids (7). Comparisons of these 
regulatory and recommended standards and methods are shown in Tables 1–3. The 
maximum allowable levels signify when a dialysis system should be taken offline (i.e., 
discontinuation of dialysis treatment in the facility), followed by appropriate treatment or 
measures applied to correct the contamination, quality assurance testing prior to 
reinstallation for patient treatment, and documentation of corrective actions in records. 
Action levels note the concentration at which steps should be taken to prevent the levels 
from increasing to the maximum allowable limits. To determine whether dialysis fluids meet 
the Conditions for Coverage or recommendations regarding chemicals and microbial 
contaminants, the water and dialysis fluids are to be tested for chemical and biological 
contaminants. The levels, if ‘in house’ testing capabilities are not adequate, can be measured 
by renal laboratories, such as DaVita Labs and Spectra laboratories, or hospital laboratories.
Chemical Standards and Methods
The maximum allowable limits for toxic chemicals (mg/l) and trace elements (mg/l) in 
municipal drinking water (23) and for dialysate water (11) are shown in Table 1. The 
chemical contaminants that can be found in water or the dialyzing fluid and have produced 
toxicity in patients are aluminum, chloramine, copper, fluoride, lead, nickel, nitrate, sulfate, 
and zinc (9,10,24–32). AAMI has recommended lower maximum allowable limits of these 
potential contaminants for dialysis water and associated fluids to below the levels associated 
with dialysis toxicity, and has also included limits for chemical contaminants (trace 
elements) based on regulations for drinking water. The trace elements limits in Table 1 were 
adopted from the U.S. EPA drinking water standards (33) with one-tenth of the maximum 
allowable limits for all but selenium and chromium. Selenium and chromium have higher 
allowable limits because “a restriction is not needed below the level at which there is no 
passage from the dialysis fluid to the blood” (11).
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The initial AAMI standard in 2003 (34) included limits for barium, selenium, chromium, 
silver, cadmium, mercury, and arsenic. The SDWA included new restrictions on chemical 
contaminants (antimony, beryllium, and thallium) and decreased the allowable concentration 
of cadmium, thus these were incorporated into the dialysis chemical limitations (11). 
Electrolytes normally included in dialysis fluids are also monitored for maximum allowable 
levels and are as follows: calcium ≤2 mg/l, magnesium ≤4 mg/l, potassium ≤8 mg/l, and 
sodium ≤70 mg/l (11). Approved methods for monitoring toxic chemicals and trace elements 
are described in the guidance documents of the American Public Health Association (35) 
and U.S. EPA (33). If a facility is unable to process samples using these approved methods, 
there are equivalent analytical methods available (11). Compliance can be met by comparing 
the source waters to the regulations set by the World Health Organization or local 
regulations, where the total heavy metals measure below 0.1 mg/l, or even with a reverse 
osmosis system complying with >90% rejection based on conductivity, resistivity, or total 
dissolved solids (11).
Microbial Standards and Methods
Due to scientific evaluation, outbreak data dissemination, and industrial influence, the U.S. 
microbial standards have evolved over time since the first recommendations in 1981. For 
example, a small study of pyrogenic reactions (i.e., reactions characterized by the onset of 
chills/shaking within approximately one hour of treatment followed by a fever one to two 
hours after treatment, as well as hypotension, headache, and muscle ache) in a single dialysis 
center by Favero et al. (1974) demonstrated that when dialysate had bacterial counts lower 
than 102 CFU/ml, there was a 4% attack rate; however, when concentrations exceeded 104 
CFU/ml, the attack rate for pyrogenic reactions increased to 24% (36). Additional studies 
and outbreak investigations demonstrated that the incoming water and final dialysis fluids 
should not exceed a maximum contaminant level (MCL) of 100–1000 CFU because of 
possible pyrogenic or septicemic complications (37,38). The limits were established by 
consensus as 2000 CFU/ml for the dialysate bath and one log10 lower for water used to 
prepare the dialysate as a result of these findings. However, the MCL for dialysate was 
lowered again to 200 CFU/ml in 2004 to match the water limit (39).
Standards for ultrapure dialysate were also determined, but the renal provider industry 
claimed that the cost would be too great to achieve this level of purity and pressed for the 
ultrapure qualifications to be voluntary. CMS was also responsive to their stakeholders in 
the provider community regarding the issues around potential costs associated with ultrapure 
fluids. In response to these concerns, levels were created with varying bacterial limits: 
conventional, ultrapure, and substitution fluid. CMS adopted the conventional dialysate as 
the minimum requirement. Yet, the U.S. standards were not harmonized with the 
international standards. One basis for the difference between the U.S. and international 
standards is that all limits outside the U.S. are set by pharmacopeial conventions because 
dialysate is a drug, while the U.S. categorizes dialysate as a device. For example, the 
European Renal Association recommends 100 CFU/ml total viable counts (TVC) and 0.25 
EU/ml for endotoxin for regular water, while the limits for ultrapure water are <1 CFU/10 
ml TVC and <0.03 IU/ml endotoxin (40). The Japanese Society for Dialysis Therapy (JSDT) 
also recommends <100 CFU/ml TVC for water, but only 0.05 EU/ml endotoxin for regular 
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water and standard dialysis fluid (41). The JSDT limits for ultrapure dialysate are <1 
CFU/10 ml TVC and <0.001EU/ml (41).
The current AAMI recommendations have been harmonized with the international dialysate 
community, although the CMS Conditions for Coverage do not recognize these stringent 
levels despite numerous studies supporting ultrapure hemodialysis having reduced chronic 
inflammation (13,42–56). The CMS Conditions for Coverage requires conventional dialysis 
to have <200 colony-forming unit (CFU)/ml (action level: 50 CFU/ml) for TVC for dialysis 
water and dialysate/dialysis fluid (Table 2) (5,6). However, the 2011 AAMI 
recommendations lowered the acceptable TVC to <100 CFU/ml (action level: 50 CFU/ml) 
for dialysis water and dialysate (8) in an effort to move toward international standards. If a 
facility chooses ultrapure dialysis, this should be clearly stated in their policies and 
procedures. They must also meet the recommended standards set by AAMI (6) according to 
the Final Rule (5) regardless of whether they meet the less stringent limits of the 
conventional dialysis. Ultrapure dialysis requires the TVC for the dialysate to be <0.1 
CFU/ml (no action level; Table 2) (2,8). Ultrapure dialysate is an ideal level of quality for 
patients, as studies have proved a reduction in inflammation and oxidative stress, 
improvement of iron utilization and erythropoietin response, and other positive benefits 
(51,53,57–66).
The recommended methods (e.g., pour plate, spread plate, membrane filtration), media, and 
incubation ranges allow each dialysis center to accommodate their facility with a monitoring 
program of their choice (Table 3). The methods and associated commercially available 
assays have been shown to be comparable (67), while different media types and incubation 
periods can result in varying colony concentrations (68–71). Reasoner’s 2A agar (R2A) 
results in higher colony counts than plate count agar (PCA) and tryptic soy agar (TSA) in 
water samples and dialysis fluids (69–71). Tryptone glucose extract agar (TGEA), an 
additional low nutrient media, also shows higher colony counts than TSA (68). These 
findings led to the updated recommendations for using TGEA or R2A for microbiological 
monitoring of dialysis water and fluids. However, for bicarbonate related samples, media 
containing salt (i.e., TSA, TSA-NaCl, standard methods agar (SMA+), SMA-NaCl, and 
R2A-NaCl) demonstrated higher colony counts due to the organisms thriving in saline 
conditions similar to the bicarbonate solutions (72). Specifically, the recommendation states 
to add 4% sodium bicarbonate to either TGEA or R2A (8).
Endotoxin Standard and Methods
Endotoxin is also included in the updated recommendations by AAMI. Conventional 
dialysis requires the endotoxin concentration in the dialysis water and dialysate to be <2 
EU/ml with an action level of 1 EU/ml (Table 2) (5,6). However, the 2011 AAMI 
recommendations lowered the acceptable endotoxin concentration to <0.25 EU/ml in 
dialysis water and <0.5 EU/ml in the dialysate (8). Ultrapure dialysis requires the endotoxin 
concentration in the dialysate to be <0.03 EU/ml (no action level; Table 2) (2,8). The 
standard method for measuring endotoxin concentrations is the Limulus amoebocyte lysate 
(LAL) test. While two LAL approaches (kinetic and gel-clot assay) are approved in the Final 
Rule (5,6), the 2011 recommendations mention six different testing techniques (8).
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The parameters described above are to be monitored on a “regular” basis after validation has 
been completed and the systems are functioning properly. Validation of the water treatment 
and dialysis fluid production systems is a documenting process that occurs once a new 
system is installed and operated according to the manufacturer’s recommendations to 
determine whether it consistently produces fluids of the required quality. Validation of a 
dialysis system is vital for establishing that the system can both provide the necessary water 
quality and whether the disinfection processes are sufficient at keeping the microbial 
contaminants below the maximum allowable limits.
The recommendations for routine monitoring mentioned within this section are from the 
updated 2011 recommendations by AAMI (8). The chemical contaminants within the water 
system are to be tested at least annually in combination with the evaluation of the source 
water (incoming feed water). Total chlorine should be monitored prior to each patient shift 
after the primary carbon tank to confirm that the concentration is below 0.01 mg/l. The 
dialysis storage water tanks and water distribution piping system should be monitored once a 
month, or as determined from the validation process, for microorganisms and endotoxin. 
The standard dialysis fluid from each dialysis machine within a facility should be tested at 
least once a year for bacteria and endotoxin, where regular testing is conducted on a 
different machine each month (machines are tested on a rotation). Ultrapure dialysis fluid is 
also tested monthly, but only for endotoxin. However, if the bacteria- and endotoxin-
retentive filter is validated, operated, and monitored according to the manufacturer’s 
instructions, this testing may not be necessary. Specifically for endotoxin-retentive filters, 
daily monitoring of the pressure across the filter is adequate in assuring endotoxin levels are 
within the limit.
Additionally, for anyone who develops signs and symptoms during the dialysis session, 
blood cultures and dialysate (from the patient’s machine) for cultures and endotoxin should 
be obtained as a routine part of the patient workup. Clinical symptoms may include fever 
(≥38.3°C/101°C), septic shock, chills (visible rigors), malaise, abdominal pain, nausea, 
vomiting, diarrhea, anxiety, confusion, and shortness of breath. Unlike in pyrogenic 
reactions, symptoms of septicemia typically do not resolve on cessation of dialysis 
treatment.
Monitoring is only a small part of assuring quality dialysis, but required for reimbursement 
by Medicare (5). Dialysis facilities need to have up-to-date logs that allow the technicians or 
supervisor to trend the chemical, bacterial, and endotoxin data. Facilities should also be 
proactive in disinfecting or conducting corrective measures when action levels have been 
reached, and certainly before the maximum contamination levels have been exceeded. 
Regular maintenance of the machines, knowledge of factors that impact dialysis quality, and 
pathways for corrective measures to be successful are additional keys for effective and safe 
dialysis. The monitoring data stay within the facility, but if there is an issue and State or 
CMS surveyors request reports, these data are required to be available for review.
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Overall, chemical and microbial contaminants have caused 13 and 20 outbreaks in the U.S., 
respectively (based on outbreaks reported to CDC). There were 197 patients who 
experienced a total of 217 episodes of chemical intoxication and 14 deaths as a result of the 
chemical outbreaks that were investigated by CDC between 1960 and 2007 (Table 4). 
Microbial-associated outbreaks have resulted in a total of 375 cases (patients and episodes 
combined) and 2 deaths (Table 5). Bacteria caused 10 outbreaks (including mycobacteria) 
with 145 cases and 2 deaths between 1969 and 2008; endotoxin was responsible for 6 
outbreaks with 177 cases and no deaths between 1973 and 1987. Four outbreaks were due to 
contamination with both bacteria and endotoxins with 53 cases and zero deaths. While 
outbreaks have decreased over time due to efforts to improve patient outcomes through 
professional practice guidelines and development of standards and regulatory oversight (see 
Fig. 1), chemicals, microorganisms, and endotoxins remain potential health threats. The 
peak years for outbreak investigations were between 1980 and 1989 and outbreaks 
investigated during this time were primarily associated with the introduction of high-flux 
dialysis, dialyzer reprocessing/reuse becoming a common practice among dialysis facilities, 
and errors in dialyzer reprocessing.
Chemical
Outbreaks of chemical toxicity or reported adverse events in dialysis patients are listed in 
Table 4. The reasons for patients being exposed to such toxic chemicals were water 
treatment failures at the drinking water treatment plant or dialysis center, incompatible 
dialysis solutions and distribution equipment/materials, and inadequate rinsing of dialysis 
systems after disinfection or newly installed dialysis systems. Aluminum (73), fluoride 
(24,25), chloramines (74), sulfur (75), and nitrates (27) have caused toxicity in patients due 
to water treatment failures. Water treatment failures at the drinking water provider level 
allowed aluminum and fluoride to be released at levels beyond the maximum allowable 
limits; and subsequent dialysis water treatment was inadequate in removing these 
substances. As a result, aluminum exposure resulted in seven cases of dialysis 
encephalopathy (characterized by speech and motor difficulties, seizures) and eight cases of 
fluoride exposure causing a variety of adverse effects (e.g., nausea, hypotension, substernal 
pain/pressure, diarrhea) (25,73).
Water treatment failure at the dialysis facility has been responsible for fluoride, chloramine, 
and sulfur chemical intoxication due to improper maintenance of internal treatment 
equipment and failure to perform monitoring (e.g., carbon filter, exhausted resins in 
deionized systems) prior to dialysis (24,74,75). The chemical intoxication caused by nitrates 
was due to lack of water treatment prior to home dialysis, as nitrates leached into the well 
water supply (27). Dialysis equipment containing aluminum parts has been responsible for 
aluminum toxicosis due to the incompatibility of the equipment with the acid concentrate 
component of the bicarbonate-based dialysis fluids (76,77). Hydrogen peroxide (78), sodium 
azide (79), and formaldehyde (25,80), however, were linked to chemical intoxication due to 
inadequate rinsing of the dialysis machine after disinfection procedures or of newly installed 
water treatment system components.
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Bacteria are often detected in the water of dialysis systems and health risks are present when 
the concentrations are high enough. Microbes that have been detected and pose a threat are 
as follows (81): Burkholderia cepacia, Enterobacter cloacae, Flavobacterium spp., 
Klebsiella pneumonia, Pseudomonas spp. including P. aeruginosa, Ralstonia picketti, 
Sphingomonas paucimobilis, Stenotrophomonas maltophilia, and nontuberculous 
mycobacteria (NTM) species. Fungi, specifically Candida albicans, and Phialemonium 
curvatum, have also been found in dialysis systems, but are uncommonly present or 
associated with health impacts. Candida parapsilosis, however, has been associated with 
bloodstream infections (82).
A majority of microbial-caused dialysis outbreaks (13 of 20) were associated with 
inadequate disinfection, which were directly linked to bacteria (83–87), endotoxin (88,89), 
bacteria/endotoxin mix (90–93), and NTM species (94,95) (Table 5). Inadequate disinfection 
allowed concentrations of bacteria to propagate and endotoxin to increase in the following 
scenarios: inconsistent cleaning/disinfection of the facility’s tap water and commercial 
deionizer resins (every 1–3 weeks) (84), improper disinfection of the water distribution 
system when the flow meter valves were left open (89), and poorly mixing the dialyzer 
disinfectant with water to create a disinfectant solution with a >230% gradient differential 
between the top and bottom of the working solution container (93). There were also issues in 
microbial-associated outbreaks with what was believed to be an alteration of the dialyzers’ 
permeability characteristics when multiple disinfectants (e.g., 4% formaldehyde followed 
with peracetic acid) were being used to disinfect the dialyzers (86,96), or the introduction of 
a new chemical disinfectant (i.e., RenNew-D, Alcide Corporation, Norwalk, CT) that caused 
holes in dialyzer membranes, thereby allowing organisms to pass from dialysate into the 
blood stream (97), in addition to other complicating factors.
A significant finding is that the reuse of dialyzers has been associated with 50% of the 
microbial-associated outbreaks (79,86–88,93–96,98,99). Reprocessing or reuse of dialyzers 
renders the dialyzers vulnerable to contamination from water used for rinsing, inadequate 
disinfection, and potential alterations to the permeability of the membrane. Additionally, the 
combination of using reprocessed dialyzers and subsequent inadequate disinfection had led 
to NTM outbreaks (94,95). Poor infection control practices (77) and a gram-negative 
contaminated RO water storage tank (37) were also implicated in outbreaks. Seasonality has 
also been observed with an endotoxin-associated outbreak in a dialysis center lacking an RO 
water system (100). Drought conditions had caused an algal bloom in the water source, thus 
endotoxin-rich blue-green algae was present at high concentrations in the water used to 
prepare the dialysate (100).
Infection Control
Waterborne outbreaks in dialysis are connected to infection control practices due to the 
potential for cross-contamination. For example, if the technician had contaminated water or 
dialysate on their gloves, it is feasible for the technician to transfer microorganisms to the 
patient during treatment. Another example would include dialysis machinery being 
contaminated from droplets or inoculated hands, which then could potentially infect the 
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patient. The CMS Conditions for Coverage (5) follows the Centers for Disease Control and 
Prevention publication, “Recommendations for Preventing Transmission of Infections 
Among Chronic Hemodialysis Patients” (101), also including the “Recommendations” 
narrative section for clarification.
Basic infection control practices include, but are not limited to, the following: staff wearing 
gloves while working with a dialysis patient, washing hands between patients, assuring 
items are cleaned before being introduced to a patient’s station, cleaning stations between 
patients, staff wearing personal protection equipment when appropriate (e.g., gowns), and 
keeping waste contained (101–103). Common breaches in infection control practice during 
hemodialysis treatment relevant to waterborne outbreaks include, but are not limited to, 
errors in dialyzer processing, backflow into blood lines from WHO ports, cross-
contamination with dialysis fluids (e.g., wet hands and vascular access), and occasional 
undetected membrane leaks. A successful infection control program requires properly 
trained staff (104). Unfortunately, a majority of outpatient dialysis centers (>80%) may still 
lack well-developed infection control programs due to not being associated with a hospital 
(104). Additionally, the training for dialysis technicians and surveillance are limited (104). 
Dialysis centers, however, are required to follow certain recommendations for infection 
control, training requirements, and surveillance to be covered by CMS (5).
Summary
As technology and the clinical science on renal replacement therapy improves with an 
increasing patient population, hemodialysis therapies will continue to be an evolving, yet 
increasing, health treatment in the U.S. The changing water treatment at municipalities due 
to the nation’s variable water quality, rapid developments in membrane technology and 
water disinfection, and strains on our health system are important discussion points for the 
future. Dialysis centers should emphasize the importance of education and training to their 
employees, as well as supporting adequately resourced infection control programs. 
Requiring centers to report their water quality surveillance data, with regard to chemicals 
and microorganisms, would also instill accountability among the dialysis technicians and 
allow for trends to be determined in the U.S. However, the patient should be their own best 
advocate by being knowledgeable about the potential hazards that poor water quality can 
cause in hemodialysis. For improved patient outcomes, the ultimate goal is to eventually 
transition to the use of ultrapure fluids as the technology improves and to move toward a 
common evidence-based standard that is accepted internationally.
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Reported outbreaks during dialysis treatment caused by water-associated contamination, 
where the specific causes of chemical, bacterial, endotoxin, and a combination of bacterial/
endotoxin agent(s) are noted in the legend. The asterisk over the column for the decades 
1980–1989 and 2000–2009 highlights where the first regulatory standard was mandated 
(2001) and the most recent Association for the Advancement of Medical Instruments 
(AAMI) recommendations were published (2008).
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TABLE 1
Chemical limits allowable in municipal drinking water and dialysis water (5,11,23)
Parameter Municipal drinking water Health effect Dialysis water Health effect
Toxic chemicals (mg/l)
 Aluminum
1 0.05–0.2 Anemia, osteomalacia 0.01 “Dialysis dementia”
 Chloramine
2 4.0 Eyes, nose; GI discomfort, anemia
0.1 
3 Acute hemolytic anemia
 Chlorine
2 4.0 Eyes, nose; GI discomfort, anemia
0.5 
3
 Total chlorine – 0.1
 Copper4 1.3 GI distress, liver/kidney damage 0.1
 Fluoride 4.0 Bone disease 0.2 Toxicity, bone disease
 Lead4 0.015 Neurological damage, fatal hemolysis 0.005 GI pain, muscle weakness
 Nitrate (as N) 10 Blue-baby syndrome, shortness 
breath
2.0 Methemoglobinemia
 Sulfate – 100 Nausea, metabolic acidosis
 Zinc – Nausea, vomiting, fever, anemia 0.1
Trace elements (mg/l)
 Antimony 0.006 0.006
 Arsenic 0.010 0.005
 Barium 2 0.1
 Beryllium 0.004 0.0004
 Cadmium 0.005 0.001
 Chromium 0.10 0.014
 Mercury 0.002 0.0002
 Selenium 0.05 0.09
 Silver1 0.10 0.005
 Thallium 0.002 0.002
1
This limit is part of the National Secondary Drinking Water Regulation, which is nonenforceable.
2
This is the highest allowable limit in drinking water, defined as the Maximum Residual Disinfectant Level.
3
Chloramine and Free Chlorine limits are only listed in the CMS standards, not in the ANSI/AAMI/ISO recommendations.
4
This limit is the action level if more than 10% of samples exceed this threshold.
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TABLE 2
Microbial standards for municipal drinking water, dialysis water, and dialysate (standard and ultrapure) (2,5–
8,11,23). The heterotrophic bacteria (HPC) and Total Viable Count are comparable when using Reasoners 2A 
(R2A) for 7 days at 17–23°C





Dialysis fluid Ultrapure dialysate
Heterotrophic bacteria (HPC) ≤500 CFU/ml – – –
Total Viable Count
 CMS max allowable limit
1 – <200 CFU/ml <200 CFU/ml <0.1 CFU/ml
 CMS action level
1,2 50 CFU/ml 50 CFU/ml –
 ANS max allowable limit3 – <100 CFU/ml <100 CFU/ml <0.1 CFU/ml
 ANS action level
2,3 50 CFU/ml 50 CFU/ml –
Endotoxin
 CMS max allowable limit
1 – <2 EU/ml <2 EU/ml <0.03 EU/ml
 CMS action level
1,2 1 EU/ml 1 EU/ml –
 ANS max allowable limit3 – <0.25 EU/ml <0.5 EU/ml <0.03 EU/ml
 ANS action level
2,3 0.125 EU/ml 0.25 EU/ml –
1
The Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services set the regulations for maximum allowable 
limits and action levels for dialysis facilities to be certified under the Medicare program (5); these are currently based upon the 2004 
recommendations from the Association for the Advancement of Medical Instrumentation (AAMI) (6).
2
The action level is the concentration at which corrective measures are to be immediately conducted to reduce the bacteria and/or endotoxin levels, 
which are typically 50% of the maximum allowable level.
3
The American National Standard (ANS) published through American National Standards Institute (ANSI)/AAMI/International Organization for 
Standardization (ISO) are voluntary, recommended practices for dialysis water (8,11) and dialysis fluid (7,8).
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TABLE 3
Methods, media, incubation and time for optimal bacterial monitoring


















Bicarbonate concentrates – methods, media, and incubation parameters are the same as listed above; however, for the recommended monitoring 
assay, the media should be supplemented with 4% sodium bicarbonate.
1
The current regulation (5) follows the 2004 AAMI recommendations (6).
2
TSA = Tryptic soy agar.
3
TGYE = Standard methods and plate count agar.
4
The 2011 AAMI recommendations have been updated compared to the 2004 recommendations (8).
5
TGEA = Tryptone Glucose Extract Agar.
6
R2A = Reasoner’s Agar No. 2.
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TABLE 4
Outbreaks and adverse events caused by chemical intoxication associated with water in the dialysis setting 
within the United States (modified from Arduino et al. (15)). The 13 events listed below occurred between 
1960 and 2007 for a total of 217 cases and 14 deaths
Contamination Description; cause References
Aluminum Intoxication and seizures in 7 patients; exhausted deionization tanks
 unable to remove aluminum in incoming tap water
(73)
Intoxication neurologic symptoms, dementia and elevated serum levels
 in 64 patients, 3 deaths; aluminum pump was used to transfer acid
 concentrate to the treatment area
(76)
Elevated serum levels detected in 10 patients during routine screening;
 replacement pump used to pump acid concentrate contained
 aluminum components
(77)
Chloramine Hemolytic anemia in 41 patients; residual disinfectant was not removed
 completely by the carbon tank when the facility increased the capacity
 of the water treatment system
(74)
Copper Hemolytic syndrome in 12 patients, 32 episodes with 4 fatalities; six
 hemodialysis centers had partially exhausted deionization system
 resulting in low pH water causing the formation of copper ions
(28)
Fluoride Intoxication in 8 patients, 1 death; accidental spill in hydrofluosilic
 acid at drinking water plant lead to excessive fluoride levels entering
 dialysis unit, insufficient treatment prior to dialysis
(25)
Intoxication in 9 patients, 3 deaths; exhausted deionization tanks
 discharged a bolus of fluoride
(24)
Formaldehyde Intoxication in 5 patients, 1 death; disinfectant not properly rinsed
 from the distribution system
(105)
Intoxication in 12 patients; new filtration system was installed and
 not properly rinsed
(80)
Hydrogen peroxide Decreased hemoglobin in 3 pediatric dialysis patients; H2O2 used to
 disinfect the system was not adequately rinsed from the system due
 to a flat bottom storage tank that could not be rinsed
(78)
Nitrate Patient developed methemoglobinemia; home dialysis using well
 water that contained nitrate nitrogen (94 mg/l)
(27)
Sodium azide Severe hypotension in 9 patients; dialysate contaminated with sodium
 azide used as a preservative from new ultrafilters, which were
 labeled “not for medical use”
(79)
Sulfate(s) Nausea, vomiting, chills, some with fever in 16 patients, 2 deaths;
 source water used to prepare dialysate contained volatile organic
 compounds (CS2, CH3, etc.) and additional failures
(75)
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TABLE 5
Outbreaks and adverse events caused by bacterial and/or endotoxin-associated contamination in water in the 
dialysis setting within the United States (modified from Arduino et al. 2010 (15)). The 20 events listed below 
span between 1969 and 2008 (events where reprocessing of dialyzers was a main contributor to the outbreak 
are noted by an asterisk)
Contamination Description; cause References
Bacterial Gram-negative bacteria bloodstream infections in 8 patients (Burkholderia cepecia
 complex, Ralstonia sp., Pseudomonas aeruginosa, or Stenotrophomonas maltophilia);
 Burkholderia cepacia complex found in reverse osmosis water, gram-negative
 organisms detected in a patient dialyzer and solution distribution system
(106)
Bacteremia episodes (~30) with the main gram-negative organisms being P. aeruginosa,
 Proteus, and Flavobacterium; bacteria was found in tap water and dialyzer resins,
 while no chlorine residual was detected after deionizer columns
(83)
Pseudomonas cepacia recovered from 10 patients (13 cases of peritonitis); insufficient
 disinfection of contaminated tap water that was used for cleaning dialysis machines
(84)
Nontuberculous mycobacterial (NTM) infection (Mycobacterium chelonae subspecies
 abcessus), 27 cases; detected in water samples
(85)
Pyrogenic reactions in 14 patients, 2 with bacteremia and 1 death; reverse osmosis
 water storage tank contaminated with bacteria
(36)
*Intradialytic sepsis in 9 patients; gram-negative organisms detected in predialysis
 saline rinse, the source was either the dialysis fluid or water used for rinsing the
 dialyzers between uses
(98)
*Bacteremia in 6 patients; likely source(s) of the gram-negative bacteria were the
 dialysis fluid or water used for rinsing dialyzers prior to reuse, as well as the
 improper preparation of the new disinfectant
(86)
*Bloodstream infections of Klebsiella pneumonia in 6 patients; inadequate
 disinfection of reprocessed dialyzers, as technicians’ gloves were cross
 contaminating from infected patient
(87)
Endotoxin Pyrogenic reaction in 49 patients; untreated tap water used to prepare the
 dialysate contained high levels of endotoxin
(107)
Pyrogenic reaction in 45 patients; inadequate disinfection of the fluid
 distribution system
(89)
*Pyrogenic reactions in 13 patients; bacteria was detected in tap water and water
 used to prepare the bicarbonate dialysate, endotoxin was detected in the faucet
 of the reprocessing room and the water-spraying device used for rinsing
(99)
Pyrogenic reactions in 23 patients (49 episodes); increased endotoxin levels found
 in the tap water used to prepare the dialysate
(100)
*Pyrogenic reactions in 3 patients; change in reprocessing methods potentially
 altered the permeability characteristics allowing endotoxins to pass
 through membrane
(96)
*Pyrogenic reactions in 16 patients (18 episodes); endotoxin is the believed cause
 during reuse of dialyzers, water used to rinse dialyzers and dilute the disinfect
 was contaminated with high concentrations of endotoxins (>6 ng/ml) and





Pyrogenic reactions and bacteremia in 5 patients (2 with Klebsiella pneumonia,
 1 with K. pneumonia and P. aeruginosa); distribution systems and machines
 were inadequately disinfected with sodium hypochlorite when a pump failed
 2 weeks prior to the outbreak
(90)
Pyrogenic reactions (9 episodes) and gram-negative bacteremia (5 episodes) in
 11 patients; water distribution system was not routinely disinfected, machine
 was not disinfected according to manufacturer’s instructions, poor bacterial
 assay resolution
(91)
*Pyrogenic reactions (~20) due to bacteria and/or endotoxins; reverse osmosis
 water was believed to be the source of contamination
(92)
*Pyrogenic reactions in 9 and gram-negative bacteremias in 5 patients; (93)
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Contamination Description; cause References
 inadequate mixing of Renalin disinfectant
Nontuberculous mycobacteria *A total of 27 cases with various infections: bacteremia in 14, soft-tissue infections
 in 3, and 1 with an access-graft infection, while 9 others had widely disseminated
 disease. Mycobacterium chelonae ssp. abscessus was identified in 26 isolates and
 the remaining isolate was a M. chelonae-like organism; the water treatment system
 showed widespread contamination and the processed dialyzers were contaminated
 with viable mycobacterium
(95)
*Systemic M. chelonae abscessus infections in 5 patients, 1 patient died during
 antimicrobial therapy; a hose with a spray device was contaminated with
 M. abscessus and the Renalin disinfectant concentration was not high enough
(94)
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